vs
Side-by-side financial comparison of Life360, Inc. (LIF) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $146.0M, roughly 1.1× Life360, Inc.). Life360, Inc. runs the higher net margin — 88.8% vs 71.2%, a 17.6% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 26.4%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $36.6M).
Life360, Inc. develops family-focused safety and connectivity platforms. Core offerings include real-time location sharing, emergency alerts, driving behavior analysis tools and identity theft protection. It serves consumer markets across North America, Europe and Asia-Pacific, with most revenue from tiered premium subscription plans.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
LIF vs STOK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $146.0M | $158.6M |
| Net Profit | $129.7M | $112.9M |
| Gross Margin | 75.1% | — |
| Operating Margin | 6.1% | 70.2% |
| Net Margin | 88.8% | 71.2% |
| Revenue YoY | 26.4% | 3661.1% |
| Net Profit YoY | 1425.9% | 528.0% |
| EPS (diluted) | $1.53 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $146.0M | — | ||
| Q3 25 | $124.5M | — | ||
| Q2 25 | $115.4M | — | ||
| Q1 25 | $103.6M | $158.6M | ||
| Q4 24 | $115.5M | $22.6M | ||
| Q3 24 | $92.9M | — | ||
| Q2 24 | $84.9M | — | ||
| Q1 24 | $78.2M | — |
| Q4 25 | $129.7M | — | ||
| Q3 25 | $9.8M | — | ||
| Q2 25 | $7.0M | — | ||
| Q1 25 | $4.4M | $112.9M | ||
| Q4 24 | $8.5M | $-10.5M | ||
| Q3 24 | $7.7M | — | ||
| Q2 24 | $-11.0M | — | ||
| Q1 24 | $-9.8M | — |
| Q4 25 | 75.1% | — | ||
| Q3 25 | 78.0% | — | ||
| Q2 25 | 78.4% | — | ||
| Q1 25 | 80.6% | — | ||
| Q4 24 | 74.0% | — | ||
| Q3 24 | 75.4% | — | ||
| Q2 24 | 75.0% | — | ||
| Q1 24 | 76.7% | — |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 2.1% | 70.2% | ||
| Q4 24 | 4.9% | -60.4% | ||
| Q3 24 | -5.3% | — | ||
| Q2 24 | -2.8% | — | ||
| Q1 24 | -8.2% | — |
| Q4 25 | 88.8% | — | ||
| Q3 25 | 7.9% | — | ||
| Q2 25 | 6.1% | — | ||
| Q1 25 | 4.2% | 71.2% | ||
| Q4 24 | 7.4% | -46.4% | ||
| Q3 24 | 8.3% | — | ||
| Q2 24 | -12.9% | — | ||
| Q1 24 | -12.5% | — |
| Q4 25 | $1.53 | — | ||
| Q3 25 | $0.11 | — | ||
| Q2 25 | $0.08 | — | ||
| Q1 25 | $0.05 | $1.90 | ||
| Q4 24 | $0.14 | $-0.15 | ||
| Q3 24 | $0.09 | — | ||
| Q2 24 | $-0.15 | — | ||
| Q1 24 | $-0.14 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $494.3M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $548.2M | $350.1M |
| Total Assets | $959.7M | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $494.3M | — | ||
| Q3 25 | $455.7M | — | ||
| Q2 25 | $432.7M | — | ||
| Q1 25 | $168.9M | $274.8M | ||
| Q4 24 | $159.2M | $128.0M | ||
| Q3 24 | $159.0M | — | ||
| Q2 24 | $160.8M | — | ||
| Q1 24 | $73.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $5.2M | — |
| Q4 25 | $548.2M | — | ||
| Q3 25 | $391.4M | — | ||
| Q2 25 | $366.7M | — | ||
| Q1 25 | $376.3M | $350.1M | ||
| Q4 24 | $358.5M | $229.0M | ||
| Q3 24 | $339.7M | — | ||
| Q2 24 | $326.7M | — | ||
| Q1 24 | $239.8M | — |
| Q4 25 | $959.7M | — | ||
| Q3 25 | $787.5M | — | ||
| Q2 25 | $753.6M | — | ||
| Q1 25 | $455.4M | $406.9M | ||
| Q4 24 | $441.6M | $271.6M | ||
| Q3 24 | $427.4M | — | ||
| Q2 24 | $405.9M | — | ||
| Q1 24 | $318.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $36.8M | $131.8M |
| Free Cash FlowOCF − Capex | $36.6M | $131.7M |
| FCF MarginFCF / Revenue | 25.1% | 83.0% |
| Capex IntensityCapex / Revenue | 0.2% | 0.1% |
| Cash ConversionOCF / Net Profit | 0.28× | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | $86.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | — | ||
| Q3 25 | $26.4M | — | ||
| Q2 25 | $13.3M | — | ||
| Q1 25 | $12.1M | $131.8M | ||
| Q4 24 | $12.3M | $-23.2M | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $3.3M | — | ||
| Q1 24 | $10.7M | — |
| Q4 25 | $36.6M | — | ||
| Q3 25 | $25.6M | — | ||
| Q2 25 | $12.7M | — | ||
| Q1 25 | $11.9M | $131.7M | ||
| Q4 24 | $11.2M | $-23.2M | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $3.2M | — | ||
| Q1 24 | — | — |
| Q4 25 | 25.1% | — | ||
| Q3 25 | 20.6% | — | ||
| Q2 25 | 11.0% | — | ||
| Q1 25 | 11.5% | 83.0% | ||
| Q4 24 | 9.7% | -102.7% | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 3.8% | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 1.0% | 0.2% | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | 0.28× | — | ||
| Q3 25 | 2.70× | — | ||
| Q2 25 | 1.90× | — | ||
| Q1 25 | 2.75× | 1.17× | ||
| Q4 24 | 1.45× | — | ||
| Q3 24 | 0.83× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
